Calcium channel expression and applicability as targeted therapies in melanoma
- PMID: 25710007
- PMCID: PMC4331404
- DOI: 10.1155/2015/587135
Calcium channel expression and applicability as targeted therapies in melanoma
Erratum in
-
Corrigendum to "Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma".Biomed Res Int. 2016;2016:3017536. doi: 10.1155/2016/3017536. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610370 Free PMC article.
Abstract
The remodeling of Ca(2+) signaling is a common finding in cancer pathophysiology serving the purpose of facilitating proliferation, migration, or survival of cancer cells subjected to stressful conditions. One particular facet of these adaptive changes is the alteration of Ca(2+) fluxes through the plasma membrane, as described in several studies. In this review, we summarize the current knowledge about the expression of different Ca(2+) channels in the plasma membrane of melanoma cells and its impact on oncogenic Ca(2+) signaling. In the last few years, new molecular components of Ca(2+) influx pathways have been identified in melanoma cells. In addition, new links between Ca(2+) homeostasis and specific cell processes important in melanoma tumor progression have been unveiled. Thus, not only do Ca(2+) channels appear to have a potential as prognostic markers, but their pharmacological blockade or gene silencing is hinted as interesting therapeutic approaches.
Figures
Similar articles
-
Functional expression of voltage-gated calcium channels in human melanoma.Pigment Cell Melanoma Res. 2012 Mar;25(2):200-12. doi: 10.1111/j.1755-148X.2012.00978.x. Epub 2012 Feb 2. Pigment Cell Melanoma Res. 2012. PMID: 22260517
-
EZH2: an emerging role in melanoma biology and strategies for targeted therapy.Pigment Cell Melanoma Res. 2015 Jan;28(1):21-30. doi: 10.1111/pcmr.12280. Epub 2014 Jun 27. Pigment Cell Melanoma Res. 2015. PMID: 24912396 Review.
-
Calcium channels as pharmacological targets for cancer therapy.Clin Exp Med. 2025 Mar 25;25(1):94. doi: 10.1007/s10238-025-01632-z. Clin Exp Med. 2025. PMID: 40131496 Free PMC article. Review.
-
The role of microRNAs in melanoma.Eur J Cell Biol. 2014 Jan-Feb;93(1-2):11-22. doi: 10.1016/j.ejcb.2014.02.001. Epub 2014 Feb 11. Eur J Cell Biol. 2014. PMID: 24602414 Review.
-
Metabolic features of melanoma: a gold mine of new therapeutic targets?Curr Cancer Drug Targets. 2014;14(4):357-70. doi: 10.2174/1568009614666140407113124. Curr Cancer Drug Targets. 2014. PMID: 24720363 Review.
Cited by
-
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.EMBO Rep. 2023 Apr 5;24(4):e55069. doi: 10.15252/embr.202255069. Epub 2023 Feb 6. EMBO Rep. 2023. PMID: 36744297 Free PMC article.
-
Corrigendum to "Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma".Biomed Res Int. 2016;2016:3017536. doi: 10.1155/2016/3017536. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610370 Free PMC article.
-
Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad.Cell Death Dis. 2016 Nov 3;7(11):e2447. doi: 10.1038/cddis.2016.351. Cell Death Dis. 2016. PMID: 27809305 Free PMC article.
-
Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low‑grade glioma.Oncol Rep. 2020 Mar;43(3):807-816. doi: 10.3892/or.2020.7459. Epub 2020 Jan 13. Oncol Rep. 2020. PMID: 32020219 Free PMC article.
-
P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b.Cells. 2020 May 13;9(5):1209. doi: 10.3390/cells9051209. Cells. 2020. PMID: 32414111 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous